Acellular Dermal Matrix Investigation in Breast Reconstruction (ADMIRE)
Sponsor: MCRA
Listed as NCT06456554, this observational or N/A phase trial focuses on Breast Reconstruction and remains actively recruiting participants. Sponsored by MCRA, it has been updated 12 times since 2024, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
May 4, 2026 — Present [daily]
Recruiting
Phase: NA → None
-
Feb 2026 — May 2026 [monthly]
Recruiting NA
-
Dec 2025 — Feb 2026 [monthly]
Recruiting NA
-
Sep 2025 — Dec 2025 [monthly]
Recruiting NA
-
May 2025 — Sep 2025 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Apr 2025 — May 2025 [monthly]
Recruiting NA
-
Mar 2025 — Apr 2025 [monthly]
Recruiting NA
-
Jan 2025 — Mar 2025 [monthly]
Recruiting NA
-
Nov 2024 — Jan 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Nov 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.
Contact Information
- MCRA
- RTI Surgical
For direct contact, visit the study record on ClinicalTrials.gov .